OncoSec Medical, Inc. (ONCSQ)
0.0000
0.00 (0.00%)
USD |
OTCM |
Oct 05, 16:00
OncoSec Medical Cash from Operations (Quarterly)
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2023 | -6.611M |
| October 31, 2022 | -6.127M |
| July 31, 2022 | -6.916M |
| April 30, 2022 | -5.341M |
| January 31, 2022 | -10.01M |
| October 31, 2021 | -9.868M |
| July 31, 2021 | -8.407M |
| April 30, 2021 | -12.80M |
| January 31, 2021 | -10.85M |
| October 31, 2020 | -9.739M |
| July 31, 2020 | -9.362M |
| April 30, 2020 | -8.212M |
| January 31, 2020 | -7.441M |
| October 31, 2019 | -8.131M |
| July 31, 2019 | -8.093M |
| April 30, 2019 | -7.684M |
| January 31, 2019 | -6.449M |
| October 31, 2018 | -6.778M |
| July 31, 2018 | -6.222M |
| April 30, 2018 | -5.786M |
| January 31, 2018 | -6.134M |
| October 31, 2017 | -5.080M |
| July 31, 2017 | -4.628M |
| April 30, 2017 | -4.475M |
| January 31, 2017 | -3.813M |
| Date | Value |
|---|---|
| October 31, 2016 | -4.425M |
| July 31, 2016 | -4.068M |
| April 30, 2016 | -4.731M |
| January 31, 2016 | -4.357M |
| October 31, 2015 | -4.658M |
| July 31, 2015 | -5.223M |
| April 30, 2015 | -5.062M |
| January 31, 2015 | -3.937M |
| October 31, 2014 | -3.430M |
| July 31, 2014 | -2.712M |
| April 30, 2014 | -2.438M |
| January 31, 2014 | -1.775M |
| October 31, 2013 | -2.055M |
| July 31, 2013 | -1.301M |
| April 30, 2013 | -1.639M |
| January 31, 2013 | -1.376M |
| October 31, 2012 | -1.217M |
| July 31, 2012 | -1.397M |
| April 30, 2012 | -0.941M |
| January 31, 2012 | -0.95M |
| October 31, 2011 | -0.9312M |
| July 31, 2011 | -1.042M |
| April 30, 2011 | -0.2512M |
| January 31, 2011 | -0.0115M |
| October 31, 2010 | -0.0045M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 100.78M |
| Alnylam Pharmaceuticals, Inc. | 326.72M |
| Savara, Inc. | -29.75M |
| Vericel Corp. | 16.19M |
| Biogen, Inc. | 448.90M |